Clinical guides for immunoglobulin A (IgA) nephropathy in Japan, third version

Japanese Journal of Nephrology

Volumn 53, Issue 2, 2011, Pages 123-135

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE PLANNING; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN;

GLOMERULONEPHRITIS, IGA; JAPAN; KIDNEY GLOMERULUS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RENAL DIALYSIS; RISK; SEVERITY OF ILLNESS INDEX;

EID: 79955455150     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Haas M. Histologic subclassification of IgA nephropathy : a clinico pathologic study of 244 cases. Am J Kidney Dis 1997 ; 29 : 829-842. (Pubitemid 27251835)
2. Lee KSM. Prognostic indicators of progressive renal disease in IgA nephropathy : Emergence of a new histologic grading system. Am J Kidney Dis 1997 ; 29 : 953-958.
3. Manno C, Strippoli GF, D'Altri C, et al. A novel simpler histological classification for renal survival in IgA nephropathy : a retrospective study. Am J Kidney Dis 2007 ; 49 : 763-775. (Pubitemid 46802935)
4. Shigematsu H. Histological grading and staging of IgA nephropathy. Pathol Int 47 ; 1997 : 194-202.
5. Lee HS, Lee MS, Lee SM, et al. Histological grading of IgA nephropathy predicting renal outcome : revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant 2005 ; 20 : 342-348. (Pubitemid 40276890)
6. Katafuchi R, Kiyoshi Y, Oh Y et al. Glomerular score as a prognosticator in IgA nephropathy : its usefulness and limitation. Clin Nephrol 1998 ; 49 : 1-8. (Pubitemid 28043359)
7. Tomino Y, Sakai H, Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 2003 ; 7 : 93-97.
8. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society : Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy : rationale, clinicopathological correlations, and classification. Kidney Int 2009 ; 76 : 534-545.
9. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society : Roberts ISD, Cook T, Troyanov S, et al. The Oxford classification of IgA Nephropathy : Pathology definitions, correlations and reproducibility. Kidney Int 2009 ; 76 : 546-556.
10. Wakai K, Kawamura T, Endoh M, et al. A scoring system to predict renal outcome in IgA nephropathy : from a nationwide prospective study. Nephrol Dial Transplant 2006 ; 21 : 2800-2808.
11. Kobayashi Y, Fujii K, Hiki Y, et al. Steroid therapy in IgA nephropathy : A prospective pilot study in moderate protein-uric cases. Q J Med 1986 ; 61 : 935-943. (Pubitemid 17181315)
12. Pozzi C, Bolasco P, Fogazzi G, et al. Corticosteroids in IgA nephropathy : a randomized controlled trial. Lancet 1999 ; 353 : 883-887. (Pubitemid 29126876)
13. Shoji T, Nakanishi I, Suzuki A, et al. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am J Kidney Dis 2000 ; 35 : 194-201. (Pubitemid 30070839)
14. Katafuchi R, Ikeda K, Mizumasa T, et al. Controlled, prospective trial of steroid treatment in IgA nephropathy : A limitation of low-dose prednisolone therapy. Am J Kidney Dis 2003 ; 41 : 972-983. (Pubitemid 36532131)
15. Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy : long-term results of a randomized, controlled trial. Am Soc Nephrol 2004 ; 15 : 157-163.
16. Katafuchi R, Ninomiya T, Mizumasa T, et al. The improvement of renal survival with steroid pulse therapy in IgA nephropathy. Nephrol Dial Transplant 2008 ; 23 : 3915-3920.
17. Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 2001 ; 38 : 736-743.
18. Xie Y, Nishi S, Ueno M, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int 2003 ; 63 : 1861-1867. (Pubitemid 36513334)
19. Komatsu H, Fujimoto S, Hara S, et al. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy : a controlled study. Clin J Am Soc Nephrol 2008 ; 3 : 1301-1307.
20. Yoshikawa N, Ito H, Sakai T, The Japanese Pediatric IgA Nephropathy Treatment Study Group. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 1999 ; 10 : 101-109. (Pubitemid 29034948)
21. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002 ; 13 : 142-148. (Pubitemid 34042021)
22. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 1994 ; 331 : 1194-1199. (Pubitemid 24331337)
23. Kobayashi Y, Hiki Y, Kokubo T, et al. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron 1996 ; 72 : 237-242.
24. Tomino Y, Suzuki H, Horikoshi S, et al. Multicenter trial of adrenocorticosteroids in Japanese patients with IgA nephropathy - results of the special study group (IgA nephropathy) on progressive glomerular disease, Ministry of Health, Labor and Welfare of Japan. Curr Top Steroid Res 2004 ; 4 : 93-98.
25. Moriyama T, Honda K, Nitta K, et al. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol 2004 ; 8 : 237-242. (Pubitemid 39421373)
26. Tamura S, Ueki K, Ideura H, et al. Corticosteroid therapy in patients with IgA nephropathy and impaired renal function. Clin Nephrol 2001 ; 55 : 192-195. (Pubitemid 32218983)
27. Sato M, Hotta O, Tomioka S, et al. Cohort study of advanced IgA nephropathy : efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract 2003 ; 93 : c137-145.
28. Russo D, Minutolo R, Pisani A, et al. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidey Dis 2001 ; 38 : 18-25. (Pubitemid 32611753)
29. Tomino Y, Kawamura T, Kimura K, et al. Antiproteinuric effect of olmesartan in patients with IgA nephropathy. J Nephrol 2009 ; 22 : 224-231.
30. Lee GSL, Choong HL, Chiang GSC, et al. Three-year randomized controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephropathy and renal impairment. Nephrology 1997 ; 3 : 117-121. (Pubitemid 27161092)
31. Ishii T, Kawamura T, Tsuboi N, et al. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy. Contrib Nephrol 2007 ; 157 : 114-119.